Takeru Fujimoto

Himeji, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Clinical value of prostate-specific antigen halving time as a predictor of response to first-line systemic treatment for synchronous metastatic castration-sensitive prostate cancer.

Clinical value of prostate-specific antigen halving time as a predictor of response to first-line systemic treatment for synchronous metastatic castration-sensitive prostate cancer.

Journal: International journal of clinical oncology
Published: June 19, 2026

Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot-Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report.

Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot-Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report.

Journal: IJU case reports
Published: May 16, 2026

Incidence and Predictors of Infection after Robot-Assisted Radical Prostatectomy: The Role of Peri-Operative Urine Culture.

Incidence and Predictors of Infection after Robot-Assisted Radical Prostatectomy: The Role of Peri-Operative Urine Culture.

Journal: Surgical infections
Published: February 28, 2026

Aggressive stone removal in octogenarian bedridden elderly patients: analysis of safety and impact on the reduction of recurrent stone-related events.

Aggressive stone removal in octogenarian bedridden elderly patients: analysis of safety and impact on the reduction of recurrent stone-related events.

Journal: World journal of urology
Published: November 07, 2025

Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma.

Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma.

Journal: IJU case reports
Published: November 04, 2024

Resumption of Enfortumab Vedotin Supported by Diagnosis of a Late- Onset Immune-Related Adverse Event in Metastatic Urothelial Carcinoma : A Case Report

Resumption of Enfortumab Vedotin Supported by Diagnosis of a Late- Onset Immune-Related Adverse Event in Metastatic Urothelial Carcinoma : A Case Report

Journal: Hinyokika kiyo. Acta urologica Japonica
Published: July 05, 2024

A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.

A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity.

Journal: International journal of clinical oncology
Published: May 03, 2024

Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy.

Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy.

Journal: International journal of clinical oncology
Published: March 04, 2024

The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.

The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: June 29, 2022

Incomplete sagittal septum of the bladder with cystolithiasis.

Incomplete sagittal septum of the bladder with cystolithiasis.

Journal: IJU case reports
Published: February 09, 2022

Squamous cell and urothelial carcinomas in an ileal neobladder.

Squamous cell and urothelial carcinomas in an ileal neobladder.

Journal: IJU case reports
Published: October 07, 2021

A Case of Prostatic Cancer that Had Bilateral Ureteral Metastases at Initial Diagnosis

A Case of Prostatic Cancer that Had Bilateral Ureteral Metastases at Initial Diagnosis

Journal: Hinyokika kiyo. Acta urologica Japonica
Published: March 04, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026